Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk...

Area of Science:

• Cardiovascular Genetics
• Lipid Metabolism
• Genetic Epidemiology

Background:

• Low high-density lipoprotein (HDL) cholesterol is linked to increased cardiovascular risk, but a causal relationship remains uncertain.
• Investigating the genetic basis of HDL cholesterol provides insights into its role in cardiovascular disease.

Purpose of the Study:

• To determine if genetic reduction of HDL cholesterol, caused by ABCA1 loss-of-function mutations, increases the risk of ischemic heart disease (IHD).

Main Methods:

• Analysis of three Danish cohorts (CCHS, CGPS, CIHDS) including over 41,000 individuals.
• Genotyping for four ABCA1 loss-of-function mutations and measurement of HDL cholesterol levels.
• Assessing the association between heterozygosity for ABCA1 mutations and the risk of IHD.

Main Results:

• Heterozygotes for ABCA1 mutations had significantly lower HDL cholesterol levels (17 mg/dL reduction, P < .001).
• Despite lower HDL cholesterol, heterozygotes did not show an increased risk of IHD across combined cohorts (OR, 0.93; 95% CI, 0.53-1.62).

Conclusions:

• Lower plasma HDL cholesterol levels resulting from heterozygosity for ABCA1 loss-of-function mutations are not associated with increased IHD risk.
• These findings challenge the direct causal link between low HDL cholesterol and IHD risk in this population.